Fool.com
The World's Greatest Investing Community
Results 1 - 10 of 428 : 1 2 3 4 5 6 7 8 9 Next
Sorry to see you go.
This Partnership Will Go No Further
Wyeth and Progenics call it quits.
Consistency Makes This Stock a Winner
Abbott turns in a solid quarter, but it needs to keep branching out.
Healthy Spinoffs, Happy Investors
When medical companies spin off unwanted divisions, the spinoffs can outperform the parent.
Get Ready for the Fall: NYSE Edition
The bigger they are, the harder they (might) fall.
5-Star Stocks Poised to Pop: Novo Nordisk
This stock could bring market-beating returns.
Daily Walk of Shame: Money-Hungry Drugmakers
If Allergan wins its suit against the government, consumers will really be in trouble.
Top-Rated Stocks That Treat Shareholders Right
These companies offer top corporate governance policies.
More Questions Than Answers From Elan
Things that make you go hmmm.
Abbott Labs Looks Less Lopsided
The pharma scores a nice medium-sized pickup.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK